Vanta Bioscience Share Price
13 Aug, 2026 4:01 PM (IST)
Vanta Bioscience Performance
- Today's Low
- ₹20
- Today's High
- ₹20
- 52 Week Low
- ₹15
- 52 Week High
- ₹29
- Open Price₹20
- Previous Close₹21
- Volume1,500
- 50 DMA₹21.60
- 100 DMA₹22.00
- 200 DMA₹26.40
Vanta Bioscience Chart
Investment Returns
- Over 1 Month -22.34%
- Over 3 Month + 9.11%
- Over 6 Month -1.26%
- Over 1 Year -23.4%
Smart Investing Starts Here Start SIP with Vanta Bioscience for Steady Growth!
Vanta Bioscience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 129
- PEG Ratio
- -
- Market Cap Cr
- 14
- P/B Ratio
- 0.7
- Average True Range
- 1
- EPS
- 0.2
- Dividend Yield
- 0
- MACD Signal
- 0.2
- RSI
- 38.06
- MFI
- 24.59
Latest Stock News Updates
Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026
- BSE India
- 2 months 2 weeks ago
Outcome of the Board Meeting held on 30.05.2026
- BSE India
- 2 months 2 weeks ago
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31, 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon
- BSE India
- 2 months 2 weeks ago
Vanta Bioscience Financials
Vanta Bioscience Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹22.60
- 50 Day
- ₹21.60
- 100 Day
- ₹22.00
- 200 Day
- ₹26.40
Resistance and Support
- R3 19.60
- R2 19.60
- R1 19.60
- S1 19.60
- S2 19.60
- S3 19.60
Vanta Bioscience Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-30 | Audited Results | |
| 2025-11-14 | Half Yearly Results | |
| 2025-08-01 | Audited Results | (Revised) |
| 2024-12-06 | Increase in Authorised Capital | Inter alia, to consider : (1) Conversion of unsecured loans from Promoters and others into equity shares and increase in the authorized capital as per requirement |
| 2024-11-14 | Half Yearly Results |
About Vanta Bioscience
Vanta Bioscience presently engaged in the business of Preclinical Activities. View More- NSE Symbol
- VANTABIO
- BSE Symbol
- 540729
- ISIN
- INE695X01011
Similar Stocks to Vanta Bioscience
Popular Stocks
Vanta Bioscience FAQs
Vanta Bioscience share price is ₹19 As on 16 August, 2026 | 00:29
The Market Cap of Vanta Bioscience is ₹14 Cr As on 16 August, 2026 | 00:29
The P/E ratio of Vanta Bioscience is 129 As on 16 August, 2026 | 00:29
The PB ratio of Vanta Bioscience is 0.7 As on 16 August, 2026 | 00:29
The 52 week High & Low of Vanta Bioscience is ₹29/₹14.7 respectively As on 16 August, 2026 | 00:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.